Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
Odonate Therapeutics reports 2018 executive compensation
By ExecPay News
Published: June 24, 2019
Odonate Therapeutics reported fiscal year 2018 executive compensation information on June 24, 2019.
In 2018, three executives at Odonate Therapeutics received on average a compensation package of $766K, a 63% decrease compared to previous year.
Average pay of disclosed executives at Odonate Therapeutics
Joseph P. O'Connell, Chief Medical Officer, received $1.4M in total, which decreased by 48% compared to 2017. 65% of O'Connell's compensation, or $945K, was in option awards. O'Connell also received $113K in non-equity incentive plan, $353K in salary, as well as $36K in other compensation.
John Lemkey, Chief Operating Officer, received a compensation package of $850K. 68% of the compensation package, or $578K, was in option awards.
Kevin C. Tang, Chief Executive Officer, earned $1 in 2018, which is the same as previous year.
Related executives
You may also like
Source: SEC filing on June 24, 2019.